Trials / Completed
CompletedNCT00277914
Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women
12-month Sustained Efficacy of Flibanserin v Placebo n Younger Women With HSDD in NA
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 749 (actual)
- Sponsor
- Sprout Pharmaceuticals, Inc · Industry
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
To estimate the duration of efficacy with continued treatment of double-blind flibanserin or placebo over twenty-four weeks of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Flibanserin | flibanserin flexible dosing |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2007-07-01
- First posted
- 2006-01-18
- Last updated
- 2012-03-16
Locations
65 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00277914. Inclusion in this directory is not an endorsement.